Given the half-life of approximately seven days, it is reasonable to obtain testosterone levels four weeks after starting therapy. Initial studies of testosterone patches demonstrated increases in total testosterone from a baseline 167 ng/dL to a peak of 1,154 ng/dL at 5.7 hours, with a decrease to 490 ng/dL over the next 12 hours.424 Following removal, the observed testosterone half-life was 116 minutes.425, 426 A multicenter, open label study confirmed mirroring of the circadian rhythm when the patch is applied in the evening with a morning peak of 740 ng/dL and a night-time trough of 213 ng/dL.427 If insufficient testosterone levels are achieved with one topical agent, including with dose adjustments, substitution with another topical agent is a viable treatment strategy.420
In fact, a paper came out two years ago that looked at 50,000 women with active breast cancer, and those who took vaginal estrogen died less. "And they said," Well, don't you know hormones cause blood clots and strokes and heart attacks? If she uses any of these vaginal hormone products, her estrogen level still stays around zero.
Determining how to treat low testosterone in females requires a close partnership with an experienced physician. The two most common methods for boosting testosterone in females are injections and topical creams. Along with this, even small dips in testosterone can impact overall wellness. Women’s bodies generate testosterone primarily in the ovaries and adrenal glands. When you hear the word testosterone, chances are you think of men.
And I tell my patients that every day is that we keep taking action, we show up, we get loud. Honestly, the movement that's been happening, the interest in this, the guidelines coming out, the labels getting changed, the groundswell of grassroots women standing up and saying, no more. I know this better than almost anybody else in the world. I was in Washington DC building my practice, doing all this advocacy work, yelling and screaming and seeing patients. She didn't quite see herself the way that everybody else saw her.
If the wrong doctor is chosen, the treatment may not match the patient's needs. Doctors from different specialties also treat low testosterone in different ways. Seeing the wrong type of doctor can delay this process and make symptoms worse over time. Getting the correct diagnosis is the first step to the right treatment.
So testosterone is a human hormone. And the fourth bucket we've talked about is vaginal hormones, which is separate from all the other three. So there's whole body estrogen, whole body progesterone, whole body testosterone, which we're going to talk about right now. So we have four major buckets when we're talking about hormone therapy. Again, so for you thinking that all your care should be by gynecology who also don't know how to prescribe hormone therapy, I mean, some do. You are crazy for not learning hormone therapy.
Compared to placebo, no significant changes were noted with testosterone therapy, including when the data were evaluated as a continuous or dichotomous (≥4 point change) variable. Other meta-analyses that have included observational studies with less stringent inclusion criteria have demonstrated variable improvements in fasting glucose, insulin resistance, and HbA1c levels.138, 325, 326 The rate of remission was also higher in a statistically significant manner among dysthymic men receiving testosterone therapy (53%) compared to placebo (19%).317, 318 Furthermore, additional testing, such as parathyroid hormone, calcium, and vitamin D levels, may be required. One trial with three years of follow-up showed near linear, time-dependent improvements in BMD.202 These findings are similar to other prospective, controlled data, which report an estimated 5% per year increase in BMD in men on testosterone therapy.309 Declining bone density may necessitate additional medical intervention, such as weight bearing exercise, calcium, vitamin D, or bisphosphonate medications. Given the link between LTBF and morbidity and mortality in older men, evaluating bone density is an important step in the assessment of patients with testosterone deficiency.